Adi Dayan-Schwartz MD, MHA, Asaf Rabin MD, Suzan Abd Elgani MD, Liron Kogan MD
{"title":"Secondary Cytoreduction for Isolated Infra-Renal Para-Aortic Recurrence of High-Grade Serous Ovarian Carcinoma: A Robotic Approach","authors":"Adi Dayan-Schwartz MD, MHA, Asaf Rabin MD, Suzan Abd Elgani MD, Liron Kogan MD","doi":"10.1016/j.jmig.2026.02.020","DOIUrl":"10.1016/j.jmig.2026.02.020","url":null,"abstract":"<div><h3>Objective</h3><div>To demonstrate a step-by-step robotic approach to secondary cytoreductive surgery for an isolated infra-renal para-aortic recurrence of high-grade serous ovarian carcinoma, emphasizing key anatomical landmarks, intraoperative strategy, and management of vascular injury.</div></div><div><h3>Setting</h3><div>University teaching hospital.</div></div><div><h3>Participants</h3><div>A 60-year-old woman with a history of high-grade serous ovarian carcinoma initially diagnosed via supraclavicular lymph node biopsy. Following five cycles of neoadjuvant Carboplatin-Paclitaxel chemotherapy, interval debulking surgery with complete cytoreduction, two adjuvant cycles, and PARP inhibitor maintenance therapy, she developed an isolated infra-renal para-aortic recurrence detected on PET-CT 18 months post-diagnosis.</div></div><div><h3>Interventions</h3><div>Robotic secondary cytoreductive surgery [<span><span>1</span></span>] was performed using intraureteric indocyanine green for ureteral mapping and a standardized para-aortic robotic port configuration [<span><span>2</span></span>]. The small bowel was suspended cranially with Prolene anchoring sutures for optimal retroperitoneal exposure. Dissection proceeded from the aortic bifurcation cranially toward the left renal vein, identifying and preserving the inferior mesenteric artery, left ureter, and inferior vena cava.</div><div>A 4–5 cm nodal mass spanning the para-aortic and interaortocaval spaces was resected en bloc. An intraoperative 3-mm inferior vena cava injury occurred during tumor dissection and was repaired primarily with 3-0 Prolene under low-pressure conditions. Estimated blood loss was approximately 100 mL. Table 1 details the surgical equipment used at each procedural stage, and Table 2 summarizes key technical tips and precautions for robotic-assisted infra-renal cytoreduction.</div></div><div><h3>Conclusion</h3><div>The patient recovered uneventfully, was discharged on postoperative day one, and resumed systemic Carboplatin-Caelyx chemotherapy on day 14, completing a total of six cycles. This case highlights the technical feasibility and safety of robotic para-aortic lymphadenectomy in the setting of isolated recurrence, even in the presence of vascular injury. The video is intended as a visual guide for advanced robotic gynecologic oncologic procedures, emphasizing key anatomical landmarks, surgical strategy, and complication management (<span><span>Table 1</span></span>, <span><span>Table 2</span></span>).</div></div><div><h3>Video Legend</h3><div><span><span><span><span><video><source></source></video></span><span><span>Download: <span>Download video (129MB)</span></span></span></span><span><span><p>Robotic Secondary Cytoreduction for Isolated Infra-renal Para-aortic Recurrence of High-Grade Serous Ovarian Carcinoma: Step-by-Step Surgical Technique and Intraoperative Vascular Repair.</p></span></span></span></span></div></div>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"33 10","pages":"Pages 1405-1406"},"PeriodicalIF":2.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146197481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lifan Qian MSc, Yinying Chai MSc, Shengyou Lin MD, Yibo He MSc
{"title":"Regarding “Lateral Distribution of Endometriotic Lesions: The Anatomical Recesses Hypothesis; A Systematic Review and Meta-Analysis”","authors":"Lifan Qian MSc, Yinying Chai MSc, Shengyou Lin MD, Yibo He MSc","doi":"10.1016/j.jmig.2026.03.041","DOIUrl":"10.1016/j.jmig.2026.03.041","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"33 10","pages":"Page 1554"},"PeriodicalIF":2.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147774068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ana Isabel Teixeira MD, Rafael José Vieira PhD, Margarida Suzel Lopes Martinho MD, Diego Raimondo PhD, Alberto Aguzzi MD, Noemi Salmeri MD, Lucia Lazzeri PhD, Antonio Raffone MD, Stefano Scarperi MD, Mohamed Mabrouk PhD, Renato Seracchioli PhD, Pedro Viana Pinto MD
{"title":"Prevalence of Urinary Symptoms in Women With Parametrial Endometriosis: Systematic Review and Meta-Analysis","authors":"Ana Isabel Teixeira MD, Rafael José Vieira PhD, Margarida Suzel Lopes Martinho MD, Diego Raimondo PhD, Alberto Aguzzi MD, Noemi Salmeri MD, Lucia Lazzeri PhD, Antonio Raffone MD, Stefano Scarperi MD, Mohamed Mabrouk PhD, Renato Seracchioli PhD, Pedro Viana Pinto MD","doi":"10.1016/j.jmig.2026.06.019","DOIUrl":"10.1016/j.jmig.2026.06.019","url":null,"abstract":"<div><ul><li><span>•</span><span><div>Urinary symptoms are common in parametrial endometriosis.</div></span></li><li><span>•</span><span><div>Data suggest a trend toward improvement in urinary function following surgery.</div></span></li><li><span>•</span><span><div>A significant proportion of women may experience persistent lower urinary tract symptoms after surgery.</div></span></li><li><span>•</span><span><div>Involvement of the lateral parametrium may influence postoperative urinary outcomes.</div></span></li></ul></div><div><h3>Objective</h3><div>This study aimed to evaluate the prevalence of urinary symptoms in women with parametrial endometriosis before and after surgery.</div></div><div>This study aimed to evaluate the prevalence of urinary symptoms in women with parametrial endometriosis before and after surgery.</div><div><h3>Data Sources</h3><div>We systematically searched MEDLINE, Web of Science, and Scopus through March 2025, with no language or publication year restrictions. Reference lists of included studies and relevant reviews were also screened.</div></div><div>We systematically searched MEDLINE, Web of Science, and Scopus through March 2025, with no language or publication year restrictions. Reference lists of included studies and relevant reviews were also screened.</div><div><h3>Methods of Study Selection</h3><div>Studies reporting pre and/or postoperative urinary symptoms in women with parametrial endometriosis were included. A systematic review and meta-analysis, including 21 articles, was conducted.</div></div><div>Studies reporting pre and/or postoperative urinary symptoms in women with parametrial endometriosis were included. A systematic review and meta-analysis, including 21 articles, was conducted.</div><div><h3>Tabulation, Integration, and Results</h3><div>Data were extracted and categorized into dysuria, lower urinary tract symptoms (LUTS), and voiding dysfunction. Preoperatively, dysuria affected 15% (95% CI: 5–35) of women, with a mean VAS score of 1.10 (95% CI: 0.90–1.30). LUTS affected 27% (95% CI: 10–56), with a mean BFLUTS score of 13.23 (95% CI: −1.26 to 27.72). Voiding dysfunction was scarcely reported before surgery. Postoperatively, the prevalence of LUTS decreased to 13% (95% CI: 7–25), and the mean BFLUTS score to 7.84 (95% CI: −0.36 to 16.03). Voiding dysfunction was experienced in 14% of women (95% CI: 5–32), and 12% were symptoms that persisted after discharge (95% CI: 6–23). Subgroup analysis suggested a trend toward lower postoperative voiding dysfunction prevalence in patients with uterosacral involvement compared with those with lateral parametrium involvement.</div></div><div>Data were extracted and categorized into dysuria, lower urinary tract symptoms (LUTS), and voiding dysfunction. Preoperatively, dysuria affected 15% (95% CI: 5–35) of women, with a mean VAS score of 1.10 (95% CI: 0.90–1.30). LUTS affected 27% (95% CI: 10–56), with a mean BFLUTS score of 13.23 (95% CI: −1.26 to 27.72). Voidi","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"33 10","pages":"Pages 1432-1447"},"PeriodicalIF":2.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148283887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Evangelia Deligeoroglou, Andreas Zouridis, Sofia Tsiapakidou, Dimitrios Zouzoulas, Dimitrios Tsolakidis, Dimitrios Mavrelos, Grigorios Grimbizis
{"title":"Sexual Function Outcomes After Minimally Invasive Uterus-Preserving Fibroid Treatment: A Systematic Review and Meta-analysis.","authors":"Evangelia Deligeoroglou, Andreas Zouridis, Sofia Tsiapakidou, Dimitrios Zouzoulas, Dimitrios Tsolakidis, Dimitrios Mavrelos, Grigorios Grimbizis","doi":"10.1016/j.jmig.2026.09.467","DOIUrl":"https://doi.org/10.1016/j.jmig.2026.09.467","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate postoperative sexual function outcomes following minimally invasive uterus-preserving treatments for uterine fibroids and to quantitatively synthesize the available evidence using validated patient-reported outcome measures, while narratively summarizing other patient-reported outcomes, including pelvic pain.</p><p><strong>Data sources: </strong>A systematic literature search was conducted in PubMed/MEDLINE, Scopus, and Google Scholar from database inception to the final search date. The review was conducted in accordance with the PRISMA 2020 guidelines and prospectively registered in PROSPERO (CRD420261392260).</p><p><strong>Methods of study selection: </strong>Studies including reproductive-age women undergoing minimally invasive uterus-preserving fibroid treatment and reporting postoperative sexual function and/or other patient-reported outcomes, including pelvic pain, using validated instruments were eligible. Studies without extractable quantitative data for sexual function outcomes were excluded. Two reviewers independently screened studies and extracted data.</p><p><strong>Tabulation, integration and results: </strong>Sixty-seven records were identified, and 11 full-text articles were assessed for eligibility. Four studies involving 382 women met the inclusion criteria and were included in the quantitative synthesis. Sexual function was primarily assessed using the Female Sexual Function Index (FSFI) and the Brief Index of Sexual Functioning for Women (BISF-W). Random-effects meta-analysis suggested an improvement in postoperative sexual function following treatment (standardized mean difference [SMD] 0.65; 95% confidence interval [CI], 0.28-1.03; p = 0.001). However, these findings should be interpreted cautiously because only four studies were included, most of which were observational, and substantial heterogeneity was present (I² = 90.3%). Publication bias could not be reliably assessed because of the limited number of included studies.</p><p><strong>Conclusion: </strong>The available evidence suggests that minimally invasive uterus-preserving fibroid treatments may be associated with improved postoperative sexual function. However, these findings should be interpreted as exploratory, given the limited number of included studies, the predominance of observational evidence, and substantial heterogeneity. Larger prospective studies with standardized outcome reporting are needed to confirm these findings.</p>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149110619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marie J. Salem MD, Maria A. Akl MD, Zaki Sleiman MD
{"title":"Laparoscopic Davydov Neovagina Creation in Mayer–Rokitansky–Küster–Hauser Syndrome With Pancake Kidney and a Solitary Ureter Using Dual Indocyanine Green Fluorescence Guidance","authors":"Marie J. Salem MD, Maria A. Akl MD, Zaki Sleiman MD","doi":"10.1016/j.jmig.2026.02.043","DOIUrl":"10.1016/j.jmig.2026.02.043","url":null,"abstract":"<div><h3>Study Objective</h3><div>To demonstrate a novel dual indocyanine green (ICG) fluorescence-guided laparoscopic Davydov procedure for neovagina creation in a patient with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome and a pancake kidney with a solitary ureter.</div></div><div>To demonstrate a novel dual indocyanine green (ICG) fluorescence-guided laparoscopic Davydov procedure for neovagina creation in a patient with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome and a pancake kidney with a solitary ureter.</div><div><h3>Design</h3><div>Video article demonstrating a surgical technique.</div></div><div>Video article demonstrating a surgical technique.</div><div><h3>Setting</h3><div>Tertiary referral center.</div></div><div>Tertiary referral center.</div><div><h3>Interventions</h3><div>A 24-year-old woman with MRKH syndrome and a right-sided pancake kidney with a single ureter presented for definitive surgical management. Total laparoscopic Davydov neovagina creation was performed with dual fluorescence guidance. Prophylactic intravenous cefazolin (2 g) was administered at induction in accordance with institutional guidelines. An ICG-soaked rectal pad was positioned to delineate the rectal boundary during rectovaginal tunnel development under near-infrared imaging. Cystoscopy confirmed solitary ureteral anatomy, followed by selective ureteral catheterization and intraluminal ICG instillation to enable continuous real-time visualization during peritoneal mobilization and suturing. The neovaginal pouch was constructed using mobilized peritoneum circumferentially sutured to the introitus with extracorporeal knot-tying, followed by standardized postoperative stenting and dilation.</div></div><div>A 24-year-old woman with MRKH syndrome and a right-sided pancake kidney with a single ureter presented for definitive surgical management. Total laparoscopic Davydov neovagina creation was performed with dual fluorescence guidance. Prophylactic intravenous cefazolin (2 g) was administered at induction in accordance with institutional guidelines. An ICG-soaked rectal pad was positioned to delineate the rectal boundary during rectovaginal tunnel development under near-infrared imaging. Cystoscopy confirmed solitary ureteral anatomy, followed by selective ureteral catheterization and intraluminal ICG instillation to enable continuous real-time visualization during peritoneal mobilization and suturing. The neovaginal pouch was constructed using mobilized peritoneum circumferentially sutured to the introitus with extracorporeal knot-tying, followed by standardized postoperative stenting and dilation.</div><div><h3>Conclusion</h3><div>Dual-structure ICG fluorescence guidance represents an innovative and reproducible adjunct for laparoscopic Davydov neovagina creation. Simultaneous visualization of the rectum and a solitary ureter in the setting of complex renal fusion anomalies enhances anatomic precision and may improve surgical safety during technically d","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"33 10","pages":"Page 1408"},"PeriodicalIF":2.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147390313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Regarding “Combined Vaginal and Laparoscopic Approach for the Creation of Neovagina in a Patient Affected by Mayer-Rokitansky-Küster-Hauser Syndrome: An Innovative Surgical Treatment”","authors":"Preeti Lamba MD","doi":"10.1016/j.jmig.2026.03.026","DOIUrl":"10.1016/j.jmig.2026.03.026","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"33 10","pages":"Pages 1550-1551"},"PeriodicalIF":2.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147529978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}